Indefinite Delivery Contract SPE2DX15D5003

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. The contract has an original award date of March 10, 2015 and a ceiling value of $4,999,999.00, with an ultimate completion date of December 31, 2025.

Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has also been awarded a separate Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for providing pharmaceutical products and medical supplies to the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.